- cafead Apr 20, 2023 at 12:02: PM
via Amgen has scored a win in its bid to defend its key immunology drug Otezla.
The U.S. Court of Appeals for the Federal Circuit backed a 2021 ruling against Novartis' Sandoz and Zydus. That prior ruling found the generics companies' products would infringe three Amgen patents.
article source
The U.S. Court of Appeals for the Federal Circuit backed a 2021 ruling against Novartis' Sandoz and Zydus. That prior ruling found the generics companies' products would infringe three Amgen patents.
article source